SHANGHAI, Jan 30 () - Sciwind Biosciences' type 2 diabetes treatment Xianyida was approved for use ​in China, the company ...

Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also ...

Rob Schneider's wife files for divorce after 14 years of marriage A secret FBI bust nabbed an alleged drug lord—and rocked ...

Patients know about nausea and vomiting. Now, lawsuits are raising concerns about vision loss.

Sales rose 2 percent overall in 2025, driven by the strong performance of several oncology drugs, including greater uptake of HER2 treatment Phesgo.

Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.

Eli Lilly is already one of the most innovative companies in the pharmaceutical industry. Over the past five years, it has ...

As part of the deal, Repertoire Immune Medicines will develop up to three drug candidates that target the drivers of certain autoimmune diseases.

Although Amgen does not yet have a GLP-1 drug approved for the market, this situation may change in the future. With a market capitalization of approximately $950 billion, Eli Lilly (LLY) has risen ...

HONG KONG, Jan. 28, 2026 /PRNewswire/ -- (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That ...

The Washington Post tested ChatGPT Health and Claude with Apple Watch data. Both issued heart-health “grades” that physicians ...

In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist ...